WallStreetZenWallStreetZen

NASDAQ: ATHA
Athira Pharma Inc Stock

$2.55-0.01 (-0.39%)
Updated May 29, 2024
ATHA Price
$2.55
Fair Value Price
$2.34
Market Cap
$97.74M
52 Week Low
$1.33
52 Week High
$4.30
P/E
-0.84x
P/B
0.92x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$116.19M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.25
Operating Cash Flow
-$100M
Beta
1.32
Next Earnings
Jul 18, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ATHA Overview

Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company developing small molecules to restore neuronal health and stop neurodegeneration brought on by Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease.Known as M3 Biotechnology, Inc. until 2019/04, the company was incorporated in 2011 and is headquartered in Bothell, WA.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ATHA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ATHA ($2.55) is overvalued by 8.94% relative to our estimate of its Fair Value price of $2.34 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ATHA ($2.55) is not significantly undervalued (8.94%) relative to our estimate of its Fair Value price of $2.34 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ATHA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ATHA due diligence checks available for Premium users.

Be the first to know about important ATHA news, forecast changes, insider trades & much more!

ATHA News

Valuation

ATHA fair value

Fair Value of ATHA stock based on Discounted Cash Flow (DCF)
Price
$2.55
Fair Value
$2.34
Overvalued by
8.94%
ATHA ($2.55) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ATHA ($2.55) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ATHA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ATHA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.84x
Industry
15.85x
Market
31x

ATHA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.92x
Industry
5.94x
ATHA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ATHA's financial health

Profit margin

Revenue
$0.0
Net Income
-$26.3M
Profit Margin
0%
ATHA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$133.5M
Liabilities
$26.7M
Debt to equity
0.25
ATHA's short-term assets ($128.64M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATHA's short-term assets ($128.64M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATHA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$25.8M
Investing
$13.0M
Financing
$0.0
ATHA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ATHA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ATHA$97.74M-0.39%-0.84x0.92x
BLUE$98.51M-4.15%-1.50x0.44x
TLSA$96.59M+1.96%-5.51x17.45x
EPRX$99.03M-1.07%N/A5.07x
VOR$96.25M-6.62%-0.80x0.78x

Athira Pharma Stock FAQ

What is Athira Pharma's quote symbol?

(NASDAQ: ATHA) Athira Pharma trades on the NASDAQ under the ticker symbol ATHA. Athira Pharma stock quotes can also be displayed as NASDAQ: ATHA.

If you're new to stock investing, here's how to buy Athira Pharma stock.

What is the 52 week high and low for Athira Pharma (NASDAQ: ATHA)?

(NASDAQ: ATHA) Athira Pharma's 52-week high was $4.30, and its 52-week low was $1.33. It is currently -40.67% from its 52-week high and 91.73% from its 52-week low.

How much is Athira Pharma stock worth today?

(NASDAQ: ATHA) Athira Pharma currently has 38,328,652 outstanding shares. With Athira Pharma stock trading at $2.55 per share, the total value of Athira Pharma stock (market capitalization) is $97.74M.

Athira Pharma stock was originally listed at a price of $17.11 in Sep 18, 2020. If you had invested in Athira Pharma stock at $17.11, your return over the last 3 years would have been -85.1%, for an annualized return of -46.98% (not including any dividends or dividend reinvestments).

How much is Athira Pharma's stock price per share?

(NASDAQ: ATHA) Athira Pharma stock price per share is $2.55 today (as of May 29, 2024).

What is Athira Pharma's Market Cap?

(NASDAQ: ATHA) Athira Pharma's market cap is $97.74M, as of May 30, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Athira Pharma's market cap is calculated by multiplying ATHA's current stock price of $2.55 by ATHA's total outstanding shares of 38,328,652.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.